Monday, October 12, 2015

Eli Lilly and China's Innovent Expand Partnership

Eli Lilly and Innovent Biologics have expanded their collaboration deal and defined the distribution rights for up to three co-developed, experimental cancer drugs.

from WSJ.com: US Business http://ift.tt/1G9iB4L
via IFTTT

No comments:

Post a Comment